| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1112854717 |
| P356 | DOI | 10.1186/S13287-019-1202-4 |
| P932 | PMC publication ID | 6421680 |
| P698 | PubMed publication ID | 30885254 |
| P2093 | author name string | John Garcia | |
| Sally Roberts | |||
| Charlotte Hulme | |||
| Karina Wright | |||
| Claire Mennan | |||
| P2860 | cites work | Exploring the full spectrum of macrophage activation | Q24653754 |
| Type VIII collagen stimulates smooth muscle cell migration and matrix metalloproteinase synthesis after arterial injury | Q24669720 | ||
| Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells | Q24681395 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation | Q84968409 | ||
| Optimization and scale-up of Wharton's jelly-derived mesenchymal stem cells for clinical applications | Q85110777 | ||
| Development of large-scale manufacturing of adipose-derived stromal cells for clinical applications using bioreactors and human platelet lysate | Q88374292 | ||
| Characterization and cost-benefit analysis of automated bioreactor-expanded mesenchymal stem cells for clinical applications | Q91377215 | ||
| Cryopreserved Off-the-Shelf Allogeneic Adipose-Derived Stromal Cells for Therapy in Patients with Ischemic Heart Disease and Heart Failure-A Safety Study. | Q48112701 | ||
| Pooled human serum: A new culture supplement for bioreactor-based cell therapies. Preliminary results | Q50074736 | ||
| Evaluation of a cell-banking strategy for the production of clinical grade mesenchymal stromal cells from Wharton's jelly. | Q50914748 | ||
| Possible role of the 'IDO-AhR axis' in maternal-foetal tolerance. | Q51280676 | ||
| Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports. | Q51575936 | ||
| High passage number of stem cells adversely affects stem cell activation and myocardial protection. | Q51776060 | ||
| Injectable cultured bone marrow-derived mesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: a prospective, randomized controlled clinical trial with 2 years' follow-up. | Q53099155 | ||
| Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues | Q53745526 | ||
| Quantum cell expansion system: Safe and rapid expansion. | Q53940591 | ||
| GMP Production and Scale-Up of Adherent Neural Stem Cells with a Quantum Cell Expansion System. | Q55515982 | ||
| GMP-Compliant Isolation and Expansion of Bone Marrow-Derived MSCs in the Closed, Automated Device Quantum Cell Expansion System | Q60628176 | ||
| Differential distribution of B7.1 (CD80) and B7.2 (CD86) costimulatory molecules on mucosal macrophage subsets in human inflammatory bowel disease (IBD) | Q73836005 | ||
| Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells | Q82335420 | ||
| The problem is obvious, the solution is not: numbers do matter in cardiac cell therapy! | Q84918254 | ||
| Multilineage potential of adult human mesenchymal stem cells | Q27860737 | ||
| Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
| Influence of the mannose receptor in host immune responses | Q28307450 | ||
| The alpha(1)beta(1) and alpha(2)beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis | Q28344804 | ||
| The M1 and M2 paradigm of macrophage activation: time for reassessment | Q29615845 | ||
| Mesenchymal stem cells | Q29619804 | ||
| Aging of mesenchymal stem cell in vitro. | Q33236089 | ||
| Structure/function relationships of CD14. | Q33801950 | ||
| Joint morphogenetic cells in the adult mammalian synovium | Q33860659 | ||
| Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the Quantum Cell Expansion System. | Q33864713 | ||
| Genetic stability of bone marrow-derived human mesenchymal stromal cells in the Quantum System | Q33977993 | ||
| Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton's jelly derived mesenchymal stem cells? A comparative study | Q34586865 | ||
| Immune modulation to improve tissue engineering outcomes for cartilage repair in the osteoarthritic joint | Q35064664 | ||
| Integrin alpha1beta1 mediates a unique collagen-dependent proliferation pathway in vivo | Q36256242 | ||
| The macrophage scavenger receptor CD163. | Q36257860 | ||
| Characterisation of synovial fluid and infrapatellar fat pad derived mesenchymal stromal cells: The influence of tissue source and inflammatory stimulus. | Q36793110 | ||
| A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia | Q36944312 | ||
| Isolation and characterisation of mesenchymal stem cells from different regions of the human umbilical cord | Q37091078 | ||
| Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I/II). | Q37211983 | ||
| Mesenchymal stromal cells derived from whole human umbilical cord exhibit similar properties to those derived from Wharton's jelly and bone marrow | Q37393107 | ||
| Efficacy of umbilical cord-derived mesenchymal stem cell-based therapy for osteonecrosis of the femoral head: A three-year follow-up study | Q37403407 | ||
| Culture expansion of adipose derived stromal cells. A closed automated Quantum Cell Expansion System compared with manual flask-based culture. | Q37419366 | ||
| Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the Internatio | Q37691742 | ||
| Macrophage plasticity and polarization in tissue repair and remodelling | Q38055370 | ||
| A randomised double-blind, placebo-controlled trial of allogeneic umbilical cord-derived mesenchymal stem cell for lupus nephritis | Q39191234 | ||
| Treatment of Knee Osteoarthritis With Allogeneic Bone Marrow Mesenchymal Stem Cells: A Randomized Controlled Trial | Q39191801 | ||
| MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation | Q39356606 | ||
| Large-scale progenitor cell expansion for multiple donors in a monitored hollow fibre bioreactor | Q39597648 | ||
| Identification and purification of mesodermal progenitor cells from human adult bone marrow. | Q41771359 | ||
| Diminished callus size and cartilage synthesis in alpha 1 beta 1 integrin-deficient mice during bone fracture healing | Q42048066 | ||
| Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro | Q42529073 | ||
| Immunological characterization of multipotent mesenchymal stromal cells--The International Society for Cellular Therapy (ISCT) working proposal | Q42595918 | ||
| Modulation of integrin expression on rat bone marrow cells by substrates with different surface characteristics | Q44118801 | ||
| Good manufacturing practice-compliant animal-free expansion of human bone marrow derived mesenchymal stroma cells in a closed hollow-fiber-based bioreactor | Q44589692 | ||
| Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. | Q45959326 | ||
| Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I/II study. | Q46347205 | ||
| Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. | Q46670167 | ||
| Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways | Q46762912 | ||
| Efficacy and safety of autologous cell therapies for knee cartilage defects (autologous stem cells, chondrocytes or the two): randomized controlled trial design. | Q47565858 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | belly cord | Q172563 |
| human umbilical cord mesenchymal stem cell | Q107296600 | ||
| telomere length | Q59658244 | ||
| P304 | page(s) | 99 | |
| P577 | publication date | 2019-03-18 | |
| P1433 | published in | Stem Cell Research & Therapy | Q14390536 |
| P1476 | title | A comprehensive characterisation of large-scale expanded human bone marrow and umbilical cord mesenchymal stem cells | |
| P478 | volume | 10 |
| Q104142348 | Challenges and translational considerations of mesenchymal stem/stromal cell therapy for Parkinson's disease |
| Q101476239 | Effect and mechanism of human umbilical cord mesenchymal stem cells in treating allergic rhinitis in mice |
| Q96766464 | Injected human umbilical cord-derived mesenchymal stromal cells do not appear to elicit an inflammatory response in a murine model of osteoarthritis |
| Q90748221 | Mesenchymal Stem Cell-Derived Extracellular Vesicles: Challenges in Clinical Applications |
| Q99579307 | Off-the-shelf mesenchymal stem cells from human umbilical cord tissue can significantly improve symptoms in COVID-19 patients: An analysis of evidential relations |
| Q91815545 | Polysaccharide-Based Systems for Targeted Stem Cell Differentiation and Bone Regeneration |
Search more.